Fig. 3From: Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapyChemotherapy-induced peripheral neuropathy (with 95% CIs) over time and with different measures used in patients receiving platinum chemotherapyBack to article page